{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:55:31Z","timestamp":1777874131468,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304206"],"award-info":[{"award-number":["82304206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20220254"],"award-info":[{"award-number":["BX20220254"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M732773"],"award-info":[{"award-number":["2023M732773"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023ZD0501400"],"award-info":[{"award-number":["2023ZD0501400"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.vaccine.2026.128587","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:40:17Z","timestamp":1775893217000},"page":"128587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world data"],"prefix":"10.1016","volume":"81","author":[{"given":"Zhuoru","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haodan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guihua","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.vaccine.2026.128587_bb0005","first-page":"265","article-title":"Varicella and herpes zoster vaccines: WHO position paper, june 2014","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128587_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40121-023-00899-7","article-title":"Global prevalence of varicella-associated complications: a systematic review and meta-analysis","volume":"13","author":"Shah","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128587_bb0015","first-page":"403","article-title":"Epidemiological characteristics of varicella in China, 2016\u20132019 [in chinese]","volume":"26","author":"Dong","year":"2020","journal-title":"Chin J Vaccines Immun"},{"key":"10.1016\/j.vaccine.2026.128587_bb0020","article-title":"National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis","volume":"32","author":"Feng","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128587_bb0025","article-title":"Varicella outbreaks in schools and kindergartens in shanghai, China from 2011 to 2020","volume":"17","author":"Wang","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128587_bb0030","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/archdischild-2024-327593","article-title":"Varicella: is it time for a global vaccination programme?","volume":"110","author":"Wooding","year":"2025","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2026.128587_bb0035","series-title":"Introduction of varicella vaccine","author":"World Health Organization","year":"2025"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2026.128587_bb0040","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1093\/infdis\/jiac242","article-title":"Decline in severe varicella disease during the United States varicella vaccination program: hospitalizations and deaths, 1990\u20132019","volume":"226","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128587_bb0045","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1080\/21645515.2021.1890968","article-title":"Changes in epidemiological characteristics and seroprevalence against varicella-zoster virus in school-age children after the introduction of a national immunization program in Japan","volume":"17","author":"Yasui","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128587_bb0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12879-017-2461-2","article-title":"Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany","volume":"17","author":"Wiese-Posselt","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128587_bb0055","doi-asserted-by":"crossref","DOI":"10.1017\/S095026882400102X","article-title":"Varicella vaccine effectiveness evaluation in Wuxi, China: a retrospective cohort study","volume":"152","author":"Xiu","year":"2024","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128587_bb0060","first-page":"169","article-title":"Survey on varicella vaccine coverage among children aged 1\u201314 years in China, 2020 [in chinese]","volume":"28","author":"Hu","year":"2022","journal-title":"Chin J Vaccines Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128587_bb0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/medlaw\/fwx001","article-title":"No-fault compensation for adverse events following immunization: a review of chinese law and practice","volume":"25","author":"Fei","year":"2017","journal-title":"Med Law Rev"},{"key":"10.1016\/j.vaccine.2026.128587_bb0070","doi-asserted-by":"crossref","first-page":"1211976","DOI":"10.3389\/fpubh.2023.1211976","article-title":"A review of chinas compensation program for adverse reactions following immunization","volume":"11","author":"Wang","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2026.128587_bb0075","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1186\/s12889-023-16390-4","article-title":"Investigation of non-national immunization program vaccination intentions in rural areas of China","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128587_bb0080","first-page":"62","article-title":"Improving the vaccine injury compensation mechanism from the perspective of public safety [in chinese]","volume":"13","author":"Dong","year":"2021","journal-title":"J North China Electr Power Univ (Soc Sci)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128587_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amepre.2024.08.007","article-title":"Cost-effectiveness of varicella vaccination for 1\u20134-year-olds in Shanghai, China","volume":"68","author":"Guan","year":"2025","journal-title":"Am J Prev Med"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128587_bb0090","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1080\/21645515.2021.1958608","article-title":"Economic evaluation of varicella vaccination strategies in Jiangsu province, China: a decision-tree markov model","volume":"17","author":"Wang","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128587_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12939-024-02282-5","article-title":"The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study","volume":"23","author":"Jiang","year":"2024","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.vaccine.2026.128587_bb0100","series-title":"Immunization schedule for non-NIP vaccines in Shaanxi province","author":"Shaanxi Provincial Center for Disease Control and Prevention","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128587_bb0105","series-title":"National immunization schedule and guidelines for children (2016 edition)","author":"National Health Commission of the People'\u2019s Republic of China","year":"2016"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2026.128587_bb0110","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1093\/infdis\/jiaa573","article-title":"Live attenuated varicella vaccine: prevention of varicella and of zoster","volume":"224","author":"Gershon","year":"2021","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128587_bb0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/315714","article-title":"Varicella mortality: trends before vaccine licensure in the United States, 1970\u20131994","volume":"182","author":"Meyer","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128587_bb0120","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: a 14-year prospective cohort study","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"issue":"20","key":"10.1016\/j.vaccine.2026.128587_bb0125","first-page":"2558","article-title":"Study on persistence of immunity 11 years after primary immunization with live attenuated varicella vaccine [in chinese]","volume":"36","author":"Huang","year":"2020","journal-title":"Chin J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128587_bb0130","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1017\/S0950268814002222","article-title":"Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future","volume":"143","author":"Gao","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128587_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003793","article-title":"Recommended reporting items for epidemic forecasting and prediction research: the EPIFORGE 2020 guidelines","volume":"18","author":"Pollett","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.128587_bb0140","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2017.06.077","article-title":"Parents concerns about vaccine scheduling in Shanghai, China","volume":"35","author":"Wagner","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128587_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12889-025-21348-9","article-title":"Effectiveness of a 2-dose varicella vaccination program in Changzhou, China, during the transitional period (2017-2022): a registry-based case-cohort study","volume":"25","author":"Xiong","year":"2025","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128587_bb0150","first-page":"41","article-title":"Research on social compensation system for vaccine injuries [in chinese]","volume":"11","author":"Wang","year":"2021","journal-title":"J Liaoning Admin Coll"},{"issue":"32","key":"10.1016\/j.vaccine.2026.128587_bb0155","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.32.20552","article-title":"Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006\u20132012","volume":"18","author":"Garc\u00eda Cenoz","year":"2013","journal-title":"Euro Surveill"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2026.128587_bb0160","doi-asserted-by":"crossref","first-page":"S392","DOI":"10.1093\/infdis\/jiac221","article-title":"Monitoring varicella vaccine impact on varicella incidence in the United States: surveillance challenges and changing epidemiology, 1995\u20132019","volume":"226","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128587_bb0165","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1186\/s12889-016-3738-x","article-title":"Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy","volume":"16","author":"Holl","year":"2016","journal-title":"BMC Public Health"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128587_bb0170","doi-asserted-by":"crossref","first-page":"e1064","DOI":"10.1016\/S2468-2667(22)00171-2","article-title":"Developing an effective and sustainable national immunisation programme in China: issues and challenges","volume":"7","author":"Chen","year":"2022","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128587_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2194190","article-title":"Driving more WHO-recommended vaccines in the national immunization program: issues and challenges in China","volume":"19","author":"Dai","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2026.128587_bb0180","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2014United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128587_bb0185","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128587_bb0190","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14760584.2017.1343669","article-title":"Varicella vaccination: the global experience","volume":"16","author":"Wutzler","year":"2017","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:07:31Z","timestamp":1777576051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26003956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"alternative-id":["S0264410X26003956"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128587","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world data","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128587"}}